Piper Sandler analyst Scott Siefers maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report) today and set a price target of ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

UBS increased their price target for JPMorgan shares, listed on the New York Stock Exchange (NYSE:JPM), to $287 from the ...

Presentation Operator Good morning, ladies and gentlemen. Welcome to JPMorgan Chase's Fourth Quarter 2024 Earnings Call. This ...

Data copilot company Prophecy today announced a $47M Series B extension to accelerate the AI-powered transformation of the data integration market.

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...

NEW YORK - Xavier University graduate Dr. Kim Carter Evans has been promoted to Executive Vice President and Chief Operating ...

Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess ...